Related Experiment Video
Updated: Feb 5, 2026

Imaging Cell Viability on Non-transparent Scaffolds — Using the Example of a Novel Knitted Titanium Implant
Published on: September 7, 2016
Transparency at the EMA: More Evidence Is Needed
11 Kings College, London, UK.
Abstract:
Ever since its establishment in 1995, the European Medicines Agency (EMA) has been committed to transparency. That said, as of late the Agency has been criticized for lacking it. To address this criticism, the Agency is attempting to become even more transparent. In this commentary the author argues that the EMA is now moving almost too quickly toward complete transparency. Before launching a number of new transparency initiatives, it should consider arranging some workshops on the topic as well as pretesting its communication messages before they are put in the public domain.
Related Concept Videos
The Evidence for Evolution
Nature and Nurture
Confirmation Biases
Stereotype Threat and Self-fulfilling Prophecies
Routes of Persuasion
What is Evolutionary History?

